Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer-Reference-Cited by-同舟云学术

Association of Proton Pump Inhibitors and Capecitabine Efficacy in Advanced Gastroesophageal Cancer

Published:2017-06-01 Issue:6 Volume:3 Page:767
ISSN:2374-2437
Container-title:JAMA Oncology
language:en
Short-container-title:JAMA Oncol

Author:

Chu Michael P.¹,Hecht J. Randolph²,Slamon Dennis²,Wainberg Zev A.²,Bang Yung-Jue³,Hoff Paulo M.⁴,Sobrero Alberto⁵,Qin Shukui⁶,Afenjar Karen⁷,Houe Vincent⁸,King Karen¹,Koski Sheryl¹,Mulder Karen¹,Hiller Julie Price¹,Scarfe Andrew¹,Spratlin Jennifer¹,Huang Yingjie J.⁹,Khan-Wasti Saba⁹,Chua Neil¹,Sawyer Michael B.¹

Affiliation:

1. Cross Cancer Institute, Department of Oncology, Edmonton, Alberta, Canada

2. Jonsson Comprehensive Cancer Center, Department of Clinical and Translational Research, University of California-Los Angeles, Los Angeles

3. Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea

4. Instituto do Cancer do Estado de Sao Paulo, Universidade de Sao Paolo, Sao Paolo, Brazil

5. IRCCS Ospedale San Martino IST, Medical Oncology, Largo Benzi 10 Genova, 16132, Italy

6. Department of Oncology, The 81 Hospital of the Chinese People’s Liberation Army, Nanjing, China

7. Project Management, Translational Research in Oncology (TRIO), Paris, France

8. Department of Biostatistics, TRIO, Paris, France

9. Department of Research and Development Projects, Clinical Platforms and Sciences, GlaxoSmithKline (GSK), Middlesex, United Kingdom

Publisher

American Medical Association (AMA)

Subject

Oncology,Cancer Research

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unraveling the future: Innovative design strategies and emerging challenges in HER2-targeted tyrosine kinase inhibitors for cancer therapy;European Journal of Medicinal Chemistry;2024-10

2. Impact of proton pump inhibitors on pathologic response rates following fluoropyrimidine‐based neoadjuvant chemotherapy in pancreatic cancer patients;Journal of Surgical Oncology;2024-09-11

3. Proton pump inhibitors and cancer treatments: Emerging evidence against coadministration;Cancer Treatment Reviews;2024-09

4. Differential functionality of fluoropyrimidine nucleosides for safe cancer therapy;Anti-Cancer Drugs;2024-08-20

5. Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer;The Breast;2024-08